MENU
+Compare
SXTC
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$1.60
Change
+$0.02 (+1.27%)
Capitalization
185.64M

SXTC China SXT Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction... Show more

SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SXTC with price predictions
Aug 15, 2025

SXTC sees its Stochastic Oscillator recovers from oversold territory

On August 11, 2025, the Stochastic Oscillator for SXTC moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 77 instances where the indicator left the oversold zone. In of the 77 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SXTC just turned positive on August 08, 2025. Looking at past instances where SXTC's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTC advanced for three days, in of 183 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SXTC as a result. In of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SXTC moved below its 50-day moving average on August 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SXTC crossed bearishly below the 50-day moving average on July 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SXTC entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SXTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.019) is normal, around the industry mean (16.657). P/E Ratio (0.014) is within average values for comparable stocks, (72.172). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.696). SXTC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (1.308) is also within normal values, averaging (40.190).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of traditional chinese medicines

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
No. 178 Taidong Road North
Phone
+86 52386298290
Employees
78
Web
http://www.sxtchina.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIVAF9.160.27
+3.04%
Aviva Plc
KSBI53.00N/A
N/A
K S Bancorp, Inc.
CCGFF10.12N/A
N/A
Credit Corp Group Ltd.
IVTJF7.24N/A
N/A
Investec Plc.
CNADF0.06N/A
N/A
CANADABIS CAP INC

SXTC and Stocks

Correlation & Price change

A.I.dvisor tells us that SXTC and SNDL have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTC and SNDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTC
1D Price
Change %
SXTC100%
+1.27%
SNDL - SXTC
28%
Poorly correlated
-4.27%
AYTU - SXTC
27%
Poorly correlated
+0.91%
CPHI - SXTC
24%
Poorly correlated
-2.05%
BHC - SXTC
22%
Poorly correlated
+11.05%
LNTH - SXTC
22%
Poorly correlated
-0.53%
More

Groups containing SXTC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTC
1D Price
Change %
SXTC100%
+1.27%
Pharmaceuticals: Generic
industry (227 stocks)
3%
Poorly correlated
-1.78%